Isomorphic Labs

An AI-first drug discovery company reimagining the design of medicines from first principles to solve all disease.

Isomorphic Labs is an AI-first drug discovery company that applies frontier artificial intelligence and rigorous science to the challenge of human health. Founded as a spin-off from Google DeepMind's breakthrough with AlphaFold, the company treats drug discovery as an engineering problem, stripping the process back to first principles to design medicines with unprecedented precision.

The company's core technology is the Isomorphic Labs Drug Design Engine (IsoDDE), a unified platform of predictive and generative models. This engine enables researchers to navigate vast chemical spaces, predict protein-ligand interactions, and optimize molecular properties such as solubility and metabolic behavior entirely in silico before moving to laboratory testing.

Isomorphic Labs operates through a combination of internal drug programs and strategic research collaborations with major pharmaceutical leaders. Its work spans multiple modalities, including small molecules and biologics, targeting challenging diseases that have historically been difficult to treat.

Headquartered in London, the company maintains a global presence with additional research and operational sites in Cambridge, Massachusetts, and Lausanne, Switzerland. It brings together a multi-disciplinary team of AI researchers, biologists, and medicinal chemists to accelerate the path from discovery to clinical application.

Headquarters
London, United Kingdom
Founded
2021

Industries: Pharmaceuticals, Technology

Categories: Drug Discovery

AntSpace put this profile together from public information. It may be incomplete; once Isomorphic Labs claims it, its admins can edit everything here.

Our mission

Isomorphic Labs' mission is to reimagine the drug discovery process from first principles with an AI-first approach, ultimately aiming to solve all disease by building a systematic way to discover and design medicines.

Our vision

Isomorphic Labs envisions a world where disease no longer has the final say, moving from empirical medicine toward exquisitely engineered molecules through an integrated scientific and engineering discipline.

Our culture

Isomorphic Labs fosters a pioneering interdisciplinary culture where machine learning researchers, chemists, biologists, and clinicians work side by side. The company emphasizes knowledge sharing and cross-pollination of ideas, encouraging an "intellectual agility" that allows experts to adopt a beginner's mindset when learning from other disciplines. The environment is described as fast-moving and consequential, prioritizing curiosity, creativity, and care in solving complex biological problems. Feedback loops between technologists and scientists are central to their iterative development process.

Core values

  • Thoughtful
  • Brave
  • Determined
  • Together

Specialties

  • AI-first drug design
  • Structure prediction
  • Binding affinity prediction
  • Generative chemistry models
  • Small molecule therapeutics
  • Blind pocket identification

Markets served

  • Drug Discovery
  • Artificial Intelligence

Key facts

Legal name
Isomorphic Labs Limited

Latest from Isomorphic Labs

All 3 updates

Products by Isomorphic Labs

All 1 products

Services by Isomorphic Labs

All 1 services

AI models by Isomorphic Labs

  • AlphaFold 3 (Science / biology model)
    Predicting the structure and interactions of all of life’s molecules.

All 1 AI models

Clients and partners

4 clients and partners

All 4 clients and partners

Documents

1 document

All 1 documents

Locations

  • Headquarters · London, United Kingdom (headquarters)

All 3 locations

Leadership, clients, case studies, documents and every location on AntSpace. Sign up free to see them.

Related